Merck (MRK) call put ratio 1 call to 5.9 puts
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi names top picks in software ahead of Q2 earnings
CFRA Upgrades Merck (MRK) to Buy (midday)
November 19, 2024 4:27 PM ESTCFRA upgraded Merck (NYSE: MRK) from Hold to Buy with a price target of $108.00.
For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.
Shares of Merck closed at $96.56 yesterday.
... MoreJPMorgan Reiterates Overweight Rating on Merck (MRK)
November 19, 2024 8:44 AM ESTJPMorgan analyst Chris Schott reiterated an Overweight rating and $145.00 price target on Merck (NYSE: MRK).
The analyst comments "This morning, MRK announced that the Ph3 trial for the subQ formulation of Keytruda (with berahyaluronidase alfa) met its dual primary PK endpoints, which we see as removing tail risk to the story as we think about the longer-term... More
